CD BioGlyco Launches Therapeutic Nucleic Acid Development Platform
CD BioGlyco launched its Therapeutic Nucleic Acid Development Platform. The company says the platform combines nucleic acid synthesis and delivery into a single service. Most platforms only handle one or the other, acco…
